Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries I-Mab ADR (NQ: IMAB ) 1.200 +0.100 (+9.09%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about I-Mab ADR < Previous 1 2 3 4 5 6 Next > I-Mab Stock Flashes Vital Signs With 89 RS Rating September 01, 2021 I-Mab stock had its Relative Strength Rating upgraded from 70 to 89 on Wednesday. Is this biopharma stock on your radar? Via Investor's Business Daily 10 Biggest Price Target Changes For Wednesday September 01, 2021 Rosenblatt raised Ambarella, Inc. (NASDAQ:AMBA) p... Via Benzinga I-MAB (IMAB) Q2 2021 Earnings Call Transcript August 31, 2021 IMAB earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial 12 Health Care Stocks Moving In Thursday's Intraday Session August 19, 2021 Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares moved upwards by 110.49% to $1.57 during Thursday's regular session. Trading volume for Sonnet BioTherapeutics'... Via Benzinga Why I-MAB's Stock Is Trading Higher Today May 20, 2021 I-MAB (NASDAQ:IMAB) shares are trading higher af... Via Benzinga The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical August 31, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... Via Benzinga I-Mab Stock Is Trading Lower After Unveiling Mid-Stage Trial Data Of Plonmarlimab In Hospitalized COVID-19 Patients August 11, 2021 I-Mab (NASDAQ: IMAB) has announced interim data from its Phase 2/3 study evaluating plonmarlimab (TJM2 or TJ003234) for cytokine release syndrome (CRS) in patients... Via Benzinga Exposures COVID-19 58 Biggest Movers From Yesterday August 20, 2021 Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares climbed 63.7% to close at $1.22 on Thursday after dropping 12% on Wednesday. Sonnet BioTherapeutics recently... Via Benzinga Week In Review: Kumquat Signs $2 Billion US-China Deal With Lilly For Novel Immune Drugs July 31, 2021 Kumquat Biosciences announced a $2 billion agreement with a Lilly subsidiary to discover small molecule drugs that stimulate tumor-specific immune responses in cancer patients. Lilly will make a $70... Via Talk Markets I-Mab To Start Testing Alzheimer's Candidate In Human Trials July 30, 2021 The FDA has signed off I-Mab (NASDAQ: IMAB) Investigational New Drug (IND) application for Protollin, an Alzheimer's candidate. Brigham and Women's... Via Benzinga Exposures Product Safety 62 Biggest Movers From Yesterday July 29, 2021 Gainers Flora Growth Corp. (NASDAQ: FLGC) surged 63.1% to close at $8.27. The Miami-based cannabis producer confirmed Tuesday it has signed a non-binding letter of intent to... Via Benzinga Topics Cannabis Exposures Cannabis 12 Health Care Stocks Moving In Wednesday's Intraday Session July 28, 2021 Gainers Infinity Pharmaceuticals (NASDAQ:INFI) shares moved upwards by 45.98% to $2.22 during Wednesday's regular session. As of 12:30 EST, this security is trading at... Via Benzinga 50 Stocks Moving In Wednesday's Mid-Day Session July 28, 2021 Gainers Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares jumped 59.9% to $2.43. Infinity Pharmaceuticals shares tumbled over 31% on Tuesday after the company highlighted the... Via Benzinga I-Mab Stock Moves Higher As IND For Mid-Stage Efineptakin Cancer Trial Accepted By China July 28, 2021 The National Medical Products Administration (NMPA) of China has signed off I-Mab's (NASDAQ: IMAB) IND application to initiate a Phase 2 trial of efineptakin... Via Benzinga Week In Review: Keymed Completes $378 Million IPO In Hong Kong For Antibody Drugs July 10, 2021 Keymed Biosciences of Chengdu completed a $378.5 million Hong Kong IPO to develop its portfolio of antibody candidates. The company priced the IPO at the top end of the range, and its shares rose 28%... Via Talk Markets Topics Initial Public Offering Exposures Securities Market Week In Review: BeiGene Plans $3 Billion IPO On Shanghai STAR Market July 03, 2021 BeiGene of Beijing has been approved to stage a $3 billion IPO on the Shanghai Star Stock Exchange. It will be the first Chinese biopharma to be listed in Shanghai, Hong Kong, and the US. Via Talk Markets Topics Initial Public Offering Exposures Securities Market The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus June 27, 2021 Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment. Eli Lilly and Company (NYSE: LLY) stood out among big... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts July 01, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Monday's After-Market Session June 21, 2021 Gainers Adial Pharmaceuticals (NASDAQ:ADIL Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2021 June 02, 2021 Upgrades According to Barrington Research, the prior rating for Landec Corp (NASDAQ:LNDC) was changed from Market Perform to Outperform. Landec earned $0.09 in the third... Via Benzinga Stocks That Hit 52-Week Highs On Wednesday June 30, 2021 This morning 132 companies reached new 52-week highs. Noteworthy Mentions: The largest company by market cap to break to a new 52-week high was NVIDIA (NASDAQ:NVDA... Via Benzinga Stocks That Hit 52-Week Highs On Wednesday June 16, 2021 Before 10 a.m. ET on Wednesday, 105 companies hit new 52-week highs. Interesting Facts: Toyota Motor (NYSE:TM) was the largest firm by market cap to set a new 52-... Via Benzinga Mid-Day Market Update: Yext Surges Following Upbeat Q1 Results; 1847 Goedeker Shares Slide May 28, 2021 Midway through trading Friday, the Dow traded up 0.33% to 34,578.23 while the NASDAQ rose 0.41% to 13,792.40. The S&P also rose, gaining 0.26% to 4,211.63. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes May 31, 2021 After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Biohaven, Bristol-Myers Squibb Snag FDA Approvals, Iterum UTI Drug Review On Track, Centessa Pharmaceuticals Debuts On Nasdaq May 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 27) BioCryst Pharmaceuticals,... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs May 27, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying May 21, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc... Via Benzinga Stocks That Hit 52-Week Highs On Thursday May 20, 2021 Before 10 a.m. ET Thursday, 56 stocks made new 52-week highs. Intriguing Points: The largest company by market cap to hit a new 52-week high was Novo Nordisk (NYSE:... Via Benzinga I-Mab Showcases Early Data On Uliledlimab/Atezolizumab Combo In Advanced Cancer Settings May 20, 2021 I-Mab (NASDAQ: IMAB) unveiled early results from Phase 1 study evaluating uliledlimab in combination with Roche Holdings AG’s (OTC: RHHBY)... Via Benzinga The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO May 18, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc... Via Benzinga Exposures COVID-19 < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.